Streetbeat News

Stock Prices

PAYC

Paycom Software, Inc. (NYSE:PAYC) has appointed Randy Peck as Chief Operating Officer. Additionally, Matt Paque and Jennifer Kraszewski have been promoted to Chief Legal Officer and Chief Human Resources Officer, respectively.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:16 pm

DG

Dollar General (NYSE:DG) reported better-than-expected Q1 FY24 results with sales growth of 6% YoY and EPS of $1.65. Despite this, analysts cut their price targets, and the stock fell 8.1%.

Portfolio Pulse from Avi Kapoor

May 31, 2024 | 1:11 pm

NVOS

Novo Integrated Sciences shares are trading higher following the company's approval of a $5 million stock repurchase. The board is also reviewing the possibility of increasing the repurchase amount.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:08 pm

ASTR

Astra Space, Inc. received a deficiency notice from Nasdaq for not timely filing its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024. The company is also not in compliance with Nasdaq's Minimum Bid Price Requirement and Minimum Stockholders' Equity Requirement.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:04 pm

FFIE

Faraday Future Intelligent Electric Inc (NASDAQ:FFIE) has seen a 15% rebound in its stock price after a 91% crash over eight days, driven by disappointing earnings and Nasdaq compliance issues. CEO Matthias Aydt addressed investor concerns about dilution and bankruptcy risks, leading to a positive market reaction. The company is also exploring strategic partnerships and has withdrawn its 2024 production target guidance.

Portfolio Pulse from Surbhi Jain

May 31, 2024 | 1:02 pm

NVOS

Novo Integrated Sciences has approved a $5 million stock repurchase program for open market and private transactions.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2024 | 1:01 pm

REXR

Analysts' ratings for Rexford Industrial Realty (NYSE:REXR) have varied over the last quarter, with a mix of bullish, indifferent, and somewhat bearish sentiments. The average 12-month price target has decreased to $49.0 from a previous $53.0. Key financial indicators show strong revenue growth and net margin, but lower ROE and ROA compared to industry benchmarks.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 1:01 pm

WING

Wingstop's short interest has fallen by 9.12%, with 1.57 million shares sold short, representing 5.38% of its float. This is lower than the peer group average of 10.61%. The decrease in short interest could indicate a more bullish sentiment among investors.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 1:00 pm

IMNM

In the past three months, four analysts have provided ratings for Immunome (NASDAQ:IMNM), ranging from bullish to bearish. The average 12-month price target is $29.75, with a high of $35.00 and a low of $24.00. Recent ratings include 'Overweight' from Piper Sandler and JP Morgan, 'Buy' from Guggenheim, and 'Outperform' from Wedbush. Immunome, a biopharmaceutical company, has faced a revenue decline of -56.47% and has a net margin of -12584.26%.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 1:00 pm

MNDY

Monday.Com's (NYSE:MNDY) short interest has fallen by 5.68%, with 2.10 million shares sold short, representing 5.15% of the float. This decrease in short interest could indicate a shift in market sentiment towards a more bullish outlook.

Portfolio Pulse from Benzinga Insights

May 31, 2024 | 1:00 pm